Positron Emission Tomography as a Diagnostic Tool in Infection: Present Role and Future Possibilities

Zhuang, 2005, Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders, Radiol Clin North Am, 43, 121, 10.1016/j.rcl.2004.07.005 Zhuang, 2002, 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation, Semin Nucl Med, 32, 47, 10.1053/snuc.2002.29278 Koljevic-Markovic, 2007, Persistent FDG uptake around an inguinal mesh prosthesis 25 years after implantation, Clin Nucl Med, 32, 242, 10.1097/01.rlu.0000255266.01340.c6 Julian, 2007, Uterine uptake of F-18 FDG on positron emission tomography induced by an intrauterine device: Unusual pitfall, Clin Nucl Med, 32, 128, 10.1097/01.rlu.0000251870.33485.69 Kawai, 2006, Enhancement of splenic glucose metabolism during acute malarial infection: Correlation of findings of FDG-PET imaging with pathological changes in a primate model of severe human malaria, Am J Trop Med Hyg, 74, 353, 10.4269/ajtmh.2006.74.353 Cheng, 2007, FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis, Clin Nucl Med, 32, 117, 10.1097/01.rlu.0000252217.14064.0f Shie, 2007, Round pneumonia mimicking pulmonary malignancy on F-18 FDG PET/CT, Clin Nucl Med, 32, 55, 10.1097/01.rlu.0000249628.58514.fd McDivitt, 2008, Incidental detection of Helicobacter pylori gastritis during FDG PET scanning for lymphoma, Clin Nucl Med, 33, 113, 10.1097/RLU.0b013e31815ef7e8 Zhang, 2008, Follow-up FDG PET in the evaluation of unexplained focal activity in the abdomen, Clin Nucl Med, 33, 19, 10.1097/RLU.0b013e31815c513c Yu, 2004, Chronic cholecystitis detected by FDG-PET, Clin Nucl Med, 29, 496, 10.1097/01.rlu.0000132952.14515.9c Yu, 2004, Diffuse FDG uptake in the lungs in aspiration pneumonia on positron emission tomographic imaging, Clin Nucl Med, 29, 567, 10.1097/01.rlu.0000134986.58984.5f Lustberg, 2008, FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma, Eur J Haematol, 81, 154, 10.1111/j.1600-0609.2008.01088.x Alavi, 2001, Finding infection—help from PET, Lancet, 358, 1386, 10.1016/S0140-6736(01)06491-1 Fu, 2004, Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: Arole for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation, Blood Cells Mol Dis, 32, 182, 10.1016/j.bcmd.2003.09.002 Zhao, 2002, Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: Effects of insulin and glucose loading, Nucl Med Commun, 23, 545, 10.1097/00006231-200206000-00006 Basu, 2007, Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: Can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?, Nucl Med Commun, 28, 465, 10.1097/MNM.0b013e328174447f Keidar, 2005, The diabetic foot: Initial experience with 18F-FDG PET/CT, J Nucl Med, 46, 444 Hochhold, 2006, Application of 18F-fluorodeoxyglucose and PET in evaluation of the diabetic foot PET, Clin North Am, 1, 123 Chryssikos, 2008, FDG-PET imaging can diagnose periprosthetic infection of the hip, Clin Orthop Relat Res, 466, 1338, 10.1007/s11999-008-0237-0 Zhuang, 2007, Critical role of 18F-labeled fluorodeoxyglucose PET in the management of patients with arthroplasty, Radiol Clin North Am, 45, 711, 10.1016/j.rcl.2007.05.010 Sterner, 2007, The role of [18F]fluoride positron emission tomography in the early detection of aseptic loosening of total knee arthroplasty, Int J Surg, 5, 99, 10.1016/j.ijsu.2006.05.002 Pill, 2006, Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip, J Arthroplasty, 21, 91, 10.1016/j.arth.2006.05.021 Kumar, 2008, Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography, Clin Microbiol Rev, 21, 209, 10.1128/CMR.00025-07 Meller, 2007, 18F-FDG PET and PET/CT in fever of unknown origin, J Nucl Med, 48, 35 Depas, 2007, F-18 FDG PET in infectious diseases in children, Clin Nucl Med, 32, 593, 10.1097/RLU.0b013e3180a1abe8 El-Haddad, 2006, Value of 18-fluoro-2-deoxyglucose PET in the management of patients with fever of unknown origin, PET Clin North Am, 1, 163 Venneti, 2008, Am J Pathol, 172, 1603, 10.2353/ajpath.2008.070967 Brust, 2006, Fluorodeoxyglucose imaging in healthy subjects with HIV infection: Impact of disease stage and therapy on pattern of nodal activation, Aids, 20, 985, 10.1097/01.aids.0000222070.52996.76 Lauwers, 2007, The use of positron emission tomography with (18)F-fluorodeoxyglucose for the diagnosis of vascular graft infection, Angiology, 58, 717, 10.1177/0003319707299205 Keidar, 2007, Prosthetic vascular graft infection: The role of 18F-FDG PET/CT, J Nucl Med, 48, 1230, 10.2967/jnumed.107.040253 Strobel, 2007, FDG PET/CT imaging of a gastric fistula, Clin Nucl Med, 32, 336, 10.1097/01.rlu.0000257270.97886.ad Win, 2006, Vesico-colic fistula as demonstrated by [18F]FDG-PET, Eur J Nucl Med Mol Imaging, 33, 107, 10.1007/s00259-005-1871-3 Choi, 2008, F-18 FDG PET/CT in the management of infected abdominal aortic aneurysm due to salmonella, Clin Nucl Med, 33, 492, 10.1097/RLU.0b013e31817793a0 Yu, 2006, Evaluating the role of fluorodeoxyglucose PET imaging in the management of patients with sarcoidosis, PET Clin North Am, 1, 141 Huang, 2006, Achilles tendonitis detected by FDG-PET, Clin Nucl Med, 31, 147, 10.1097/01.rlu.0000200463.66611.66 Houseni, 2006, Facet joint arthropathy demonstrated on FDG-PET, Clin Nucl Med, 31, 418, 10.1097/01.rlu.0000223155.73661.f1 Lan, 2008, The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions, Clin Radiol, 63, 756, 10.1016/j.crad.2008.01.003 Basu, 2007, Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: Should these be routinely employed in assessing patients with cancer?, Eur J Nucl Med Mol Imaging, 34, 1527, 10.1007/s00259-007-0467-5 Xiu, 2007, Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity, Clin Nucl Med, 32, 101, 10.1097/01.rlu.0000252457.54929.b7 Zhuang, 2001, Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes, J Nucl Med, 42, 1412 Lehmann, 2001, F-18-FDG uptake in granulocytes: Basis of F-18-FDG scintigraphy for imaging infection, J Nucl Med, 42, 1384 Ishimori, 2002, Increased (18)F-FDG uptake in a model of inflammation: Concanavalin A-mediated lymphocyte activation, J Nucl Med, 43, 658 Mamede, 2003, Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification, Neoplasia, 5, 179, 10.1016/S1476-5586(03)80010-6 Ahmed, 1999, Distinct regulation of glucose transport by interleukin-3 and oncogenes in a murine bone marrow-derived cell line, Biochem Pharmacol, 57, 387, 10.1016/S0006-2952(98)00267-6 Ahmed, 1997, Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst, Biochem J, 327, 369, 10.1042/bj3270369 Gamelli, 1996, Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice, J Leukoc Biol, 59, 639, 10.1002/jlb.59.5.639 Gamelli, 1994, Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice, Shock, 1, 395, 10.1097/00024382-199406000-00001 Chakrabarti, 1994, Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin, J Immunol, 152, 2660, 10.4049/jimmunol.152.6.2660 Heelan, 1998, Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography, Transplantation, 66, 1101, 10.1097/00007890-199810270-00022 Kubota, 1992, Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography, J Nucl Med, 33, 1972 Sorbara, 1996, Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression, J Virol, 70, 7275, 10.1128/JVI.70.10.7275-7279.1996 Hartmann, 2007, Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis, Eur J Nucl Med Mol Imaging, 34, 704, 10.1007/s00259-006-0290-4 Prandini, 2006, Nuclear medicine imaging of bone infections, Nucl Med Commun, 27, 633, 10.1097/00006231-200608000-00006 Robiller, 2000, Chronic osteomyelitis of the femur: Value of PET imaging, Eur Radiol, 10, 855, 10.1007/s003300051019 Zhuang, 2000, Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging, Clin Nucl Med, 25, 281, 10.1097/00003072-200004000-00009 Guhlmann, 1998, Chronic osteomyelitis: Detection with FDG PET and correlation with histopathologic findings, Radiology, 206, 749, 10.1148/radiology.206.3.9494496 Guhlmann, 1998, Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis, J Nucl Med, 39, 2145 de Winter, 2001, Fluorine-18 fluorodeoxyglucose-position emission tomography: A highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections, J Bone Joint Surg Am, 83-A, 651, 10.2106/00004623-200105000-00002 Chacko, 2003, Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection, Nucl Med Commun, 24, 615, 10.1097/00006231-200306000-00002 Pineda, 2006, Imaging of osteomyelitis: current concepts, Infect Dis Clin North Am, 20, 789, 10.1016/j.idc.2006.09.009 Palestro, 1991, Radionuclide diagnosis of vertebral osteomyelitis: Indium-111-leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy, J Nucl Med, 32, 1861 Termaat, 2005, The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: A systematic review and meta-analysis, J Bone Joint Surg Am, 87, 2464, 10.2106/JBJS.D.02691 el Esper, 1992, 99Tcm-HMPAO-labelled leucocyte scintigraphy in suspected chronic osteomyelitis related to an orthopaedic device: Clinical usefulness, Nucl Med Commun, 13, 799, 10.1097/00006231-199211000-00005 Meller, 2002, Chronic bacterial osteomyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111)In-labelled autologous leucocyte scintigraphy, Eur J Nucl Med Mol Imaging, 29, 53, 10.1007/s00259-001-0661-9 Love, 2003, 18F-FDG and 67Ga-SPECT imaging in suspected vertebral osteomyelitis: An intraindividual comparison, J Nucl Med, 45, 148P Gratz, 2002, 18F-FDG hybrid PET in patients with suspected spondylitis, Eur J Nucl Med Mol Imaging, 29, 516, 10.1007/s00259-001-0719-8 Stumpe, 2002, FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging, AJR Am J Roentgenol, 179, 1151, 10.2214/ajr.179.5.1791151 Zhuang, 2003, Rapid normalization of osseous FDG uptake following traumatic or surgical fractures, Eur J Nucl Med Mol Imaging, 30, 1096, 10.1007/s00259-003-1198-x Meyer, 1994, Increased F-18 FDG accumulation in an acute fracture, Clin Nucl Med, 19, 13, 10.1097/00003072-199401000-00004 Hopfner, 2004, Preoperative imaging of Charcot neuroarthropathy in diabetic patients: Comparison of ring PET, hybrid PET, and magnetic resonance imaging, Foot Ankle Int, 25, 890, 10.1177/107110070402501208 Hopfner, 2006, [Preoperative imaging of Charcot neuroarthropathy: Does the additional application of (18)F-FDG-PET make sense?], Nuklearmedizin, 45, 15, 10.1055/s-0038-1623931 Alnafisi, 2001, F-18 FDG positron emission tomography to differentiate diabetic osteoarthropathy from septic arthritis, Clin Nucl Med, 26, 638, 10.1097/00003072-200107000-00018 Nawaz, 2008, Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) in the diagnosis of acute osteomyelitis in the diabetic foot, J Nucl Med, 49, 134P Zhuang, 2001, Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?, Nucl Med Commun, 22, 1123, 10.1097/00006231-200110000-00011 Zhuang, 2002, Persistent non-specific FDG uptake on PET imaging following hip arthroplasty, Eur J Nucl Med Mol Imaging, 29, 1328, 10.1007/s00259-002-0886-2 Zhuang, 2001, The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants, J Nucl Med, 42, 44 Vanquickenborne, 2003, The value of (18)FDG-PET for the detection of infected hip prosthesis, Eur J Nucl Med Mol Imaging, 30, 705, 10.1007/s00259-002-1109-6 Love, 2000, Utility of F-18 FDG imaging for diagnosing the infected joint replacement, Clin Positron Imaging, 3, 159, 10.1016/S1095-0397(00)00071-6 Love, 2004, Diagnosing infection in the failed joint replacement: A comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging, J Nucl Med, 45, 1864 Stumpe, 2004, FDG PET for differentiation of infection and aseptic loosening in total hip replacements: Comparison with conventional radiography and three-phase bone scintigraphy, Radiology, 231, 333, 10.1148/radiol.2312021596 Chacko, 2002, The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses, Nucl Med Commun, 23, 851, 10.1097/00006231-200209000-00008 Zoccali C, Teori G, Salducca N: The role of FDG-PET in distinguishing between septic and aseptic loosening in hip prosthesis: A review of literature. Int Orthop 2008 Jul 2 [Epub ahead of print] Petersdorf, 1985, FUO: How it has changed in 20 years, Hosp Pract (Off Ed), 20, 10.1080/21548331.1985.11703037 Petersdorf, 1992, Fever of unknown origin, Arch Intern Med, 152, 21, 10.1001/archinte.1992.00400130047001 Blockmans, 2001, Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin, Clin Infect Dis, 32, 191, 10.1086/318480 Stumpe, 2000, Infection imaging using whole-body FDG-PET, Eur J Nucl Med, 27, 822, 10.1007/s002590000277 Gungor, 2001, Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease, Arch Dis Child, 85, 341, 10.1136/adc.85.4.341 Meller, 2000, Fever of unknown origin: Prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPECT, Eur J Nucl Med, 27, 1617, 10.1007/s002590000341 Bleeker-Rovers, 2004, Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation, Eur J Nucl Med Mol Imaging, 31, 29, 10.1007/s00259-003-1338-3 Yen, 2004, Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: A preliminary report, Acad Radiol, 11, 316, 10.1016/S1076-6332(03)00715-3 Federici L, Blondet C, Imperiale A, et al: Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: A single centre analysis experience. Int J Clin Pract 2008 May 7 [Epub ahead of print] Hoffman, 1993, FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS, J Nucl Med, 34, 567 O'Doherty, 1997, PET scanning and the human immunodeficiency virus-positive patient, J Nucl Med, 38, 1575 Heald, 1996, Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET), Int J STD AIDS, 7, 337, 10.1258/0956462961918239 Scharko, 2003, Whole-body positron emission tomography in patients with HIV-1 infection, Lancet, 362, 959, 10.1016/S0140-6736(03)14366-8 Scharko, 1996, Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques, Proc Natl Acad Sci USA, 93, 6425, 10.1073/pnas.93.13.6425 Santiago, 1999, Role of fluorine-18-fluorodeoxyglucose in the work-up of febrile AIDS patients experience with dual head coincidence imaging, Clin Positron Imaging, 2, 301, 10.1016/S1095-0397(99)00036-9 Krupnick, 2003, 18-fluorodeoxyglucose positron emission tomography as a novel imaging tool for the diagnosis of aortoenteric fistula and aortic graft infection—a case report, Vasc Endovascular Surg, 37, 363, 10.1177/153857440303700509 Rohde, 2004, Recurrent Listeria monocytogenes aortic graft infection: Confirmation of relapse by molecular subtyping, Diagn Microbiol Infect Dis, 48, 63, 10.1016/j.diagmicrobio.2003.08.003 Fukuchi, 2005, Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: Comparison with computed tomographic findings, J Vasc Surg, 42, 919, 10.1016/j.jvs.2005.07.038 Tegler, 2007, Detection of aortic graft infection by 18-fluorodeoxyglucose positron emission tomography combined with computed tomography, J Vasc Surg, 45, 828, 10.1016/j.jvs.2006.12.018 Wasikova, 2007, [Treatment of vascular prosthesis infection and aorto-enteric fistula as a late complication after reconstructive surgery of the abdominal aorta–a case report], Rozhl Chir, 86, 522 Balink, 2007, Diagnosis of abdominal aortic prosthesis infection with FDG-PET/CT, Vasc Endovascular Surg, 41, 428, 10.1177/1538574407305094 van Assen, 2007, Vascular graft infection due to chronic Q fever diagnosed with fusion positron emission tomography/computed tomography, J Vasc Surg, 46, 372, 10.1016/j.jvs.2006.10.003 Tsunekawa, 2007, Masked prosthetic graft to sigmoid colon fistula diagnosed by 18-fluorodeoxyglucose positron emission tomography, Eur J Vasc Endovasc Surg, 33, 187, 10.1016/j.ejvs.2006.06.010 Carlos, 2008, Hidden clotted vascular access infection diagnosed by fluorodeoxyglucose positron emission tomography, Nephrology (Carlton), 13, 264, 10.1111/j.1440-1797.2007.00837.x Gugatschka M, Schwarz T, Friedrich G: Positron emission tomography/computed tomography as a method for detection and monitoring of laryngeal chondritis. Eur Arch Otorhinolaryngol 2008 Mar 26 [Epub ahead of print] Cobbaert, 2007, Brucellar spondylodiscitis: Case report, Acta Clin Belg, 62, 304, 10.1179/acb.2007.046 Helleman, 2007, Mycotic aneurysm of the descending thoracic aorta. Review and case report, Acta Chir Belg, 107, 544, 10.1080/00015458.2007.11680119 Takano H, Nakagawa K, Ishio N, et al: Active myocarditis in a patient with chronic active Epstein-Barr virus infection. Int J Cardiol 2007 Oct 1 [Epub ahead of print] Maldonado, 2007, Focal organizing pneumonia on surgical lung biopsy: Causes, clinicoradiologic features, and outcomes, Chest, 132, 1579, 10.1378/chest.07-1148 Sheehy, 2007, Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT, Clin Nucl Med, 32, 820, 10.1097/RLU.0b013e318148b48f Wyss, 2004, Influence of ceftriaxone treatment on FDG uptake—an in vivo [18F]-fluorodeoxyglucose imaging study in soft tissue infections in rats, Nucl Med Biol, 31, 875, 10.1016/j.nucmedbio.2004.06.001 Hakim, 2006, The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible, Int J Oral Maxillofac Surg, 35, 809, 10.1016/j.ijom.2006.03.029 Win, 2006, F-18 FDG PET in the diagnosis and monitoring of salmonella vertebral osteomyelitis: A comparison with MRI, Clin Nucl Med, 31, 437, 10.1097/01.rlu.0000225028.30936.c5 Ozsahin, 1998, Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B, Blood, 92, 2719, 10.1182/blood.V92.8.2719 Bleeker-Rovers, 2003, Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease, Am J Kidney Dis, 41, E18, 10.1016/S0272-6386(03)00368-8 Bleeker-Rovers, 2005, Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography, Clin Microbiol Infect, 11, 493, 10.1111/j.1469-0691.2005.01155.x Win, 2005, FDG-PET imaging in Pneumocystis carinii pneumonia, Clin Nucl Med, 30, 690, 10.1097/01.rlu.0000178784.58278.36 Reuter, 2004, Structured treatment interruption in patients with alveolar echinococcosis, Hepatology, 39, 509, 10.1002/hep.20078 Ehrhardt AR, Reuter S, Buck AK, et al: Assessment of disease activity in alveolar echinococcosis: A comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography. Abdom Imaging 2007 Feb 7 [Epub ahead of print] Stumpe, 2007, F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: Prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy, Infection, 35, 11, 10.1007/s15010-007-6133-9 Chamilos, 2008, The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections, Med Mycol, 46, 23, 10.1080/13693780701639546 Li, 2008, Increased FDG uptake in bilateral adrenal tuberculosis appearing like malignancy, Clin Nucl Med, 33, 191, 10.1097/RLU.0b013e318162ddb3 Lin, 2008, Disseminated nontuberculous mycobacterial infection mimic metastases on PET/CT scan, Clin Nucl Med, 33, 276, 10.1097/RLU.0b013e3181662fb2 Takalkar, 2007, Intense FDG activity in peritoneal tuberculosis mimics peritoneal carcinomatosis, Clin Nucl Med, 32, 244, 10.1097/01.rlu.0000255239.04475.c2 Li, 2008, Systemic disseminated tuberculosis mimicking malignancy on F-18 FDG PET-CT, Clin Nucl Med, 33, 49, 10.1097/RLU.0b013e31815c5004 Park, 2008, Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography, Clin Nucl Med, 33, 1, 10.1097/RLU.0b013e31815c5128